Heterotopic atypical trophoblasts mimicking ectopic choriocarcinoma coexistent with a viable intrauterine pregnancy: A diagnostic dilemma

por Mazina, Varvara, Morse, Christopher, Hadi, Rouba, Gray, Heidi
Publicado 2019

Cognitive skill training improves memory, function, and use of cognitive strategies in cancer survivors

por Cherrier, Monique M., Higano, Celestia S., Gray, Heidi J.
Publicado 2021

Clitoral metastasis of vulvar melanoma treated with talimogene laherparepvec

por McClure, Erin M., Singh, Neha, Abson, Kim G., Bhatia, Shailender, Gray, Heidi J., Brown, Laura S., Moshiri, Ata S.
Publicado 2022

The Abandoned Radical Hysterectomy for Cervical Cancer: Clinical Predictors and Outcomes

por Gray, Heidi J., Seifert, Erin, Sal y Rosas, Victor G., Nicandri, Katrina F., Koh, Wui-Jin, Goff, Barbara A.
Publicado 2010

The association between HIV infection and cervical cancer presentation and survival in Uganda()

por Wu, Emily S., Urban, Renata R., Krantz, Elizabeth M., Mugisha, Noleb M., Nakisige, Carolyn, Schwartz, Stephen M., Gray, Heidi J., Casper, Corey
Publicado 2019

Diffusion of Intraperitoneal Chemotherapy in Women with Advanced Ovarian Cancer in Community Settings 2003–2008: The Effect of the NCI Clinical Recommendation

por Bowles, Erin J. Aiello, Wernli, Karen J., Gray, Heidi J., Bogart, Andy, Delate, Thomas, O’Keeffe-Rosetti, Maureen, Nekhlyudov, Larissa, Loggers, Elizabeth Trice
Publicado 2014

Patterns and duration of primary and recurrent treatment in ovarian cancer patients with germline BRCA mutations

por Jorge, Soledad, Swisher, Elizabeth M., Norquist, Barbara M., Pennington, Kathryn P., Gray, Heidi J., Urban, Renata R., Garcia, Rochelle L., Doll, Kemi M.
Publicado 2019

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study

por Ghezelayagh, Talayeh S., Wu, Emily S., Barber, Emma L., Dao, Minh D., Zsiros, Emese, Urban, Renata R., Gray, Heidi J., Goff, Barbara A., Shah, Chirag A., Neubauer, Nikki L., Dai, James Y., Tanyi, Janos L., Liao, John B.
Publicado 2023

Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing

por Gray, Heidi J., Chatterjee, Payel, Rosati, Rachele, Appleyard, Lauren R., Durenberger, Grace J., Diaz, Robert L., Swan, Hallie A., Peretti, Danielle, Pollastro, Maddy, Ainge, Trevor, Kapeli, Katannya, Pereira, Shalini, Margossian, Astrid L., Banda, Kalyan, Goff, Barbara A., Swisher, Elizabeth M., Bernard, Brady, Kemp, Christopher J., Grandori, Carla
Publicado 2023

NRG/RTOG 0837: Randomized, phase II, double-blind, placebo-controlled trial of chemoradiation with or without cediranib in newly diagnosed glioblastoma

por Batchelor, Tracy T, Won, Minhee, Chakravarti, Arnab, Hadjipanayis, Costas G, Shi, Wenyin, Ashby, Lynn S, Stieber, Volker W, Robins, H Ian, Gray, Heidi J, Voloschin, Alfredo, Fiveash, John B, Robinson, Clifford G, Chamarthy, UshaSree, Kwok, Young, Cescon, Terrence P, Sharma, Anand K, Chaudhary, Rekha, Polley, Mei-Yin, Mehta, Minesh P
Publicado 2023

Uterine Lavage Identifies Cancer Mutations and Increased TP53 Somatic Mutation Burden in Individuals with Ovarian Cancer

por Ghezelayagh, Talayeh S., Kohrn, Brendan F., Fredrickson, Jeanne, Manhardt, Enna, Radke, Marc R., Katz, Ronit, Gray, Heidi J., Urban, Renata R., Pennington, Kathryn P., Liao, John B., Doll, Kemi M., Simons, Elise J., Burzawa, Jennifer K., Goff, Barbara A., Speiser, Paul, Swisher, Elizabeth M., Norquist, Barbara M., Risques, Rosa Ana
Publicado 2022